» Articles » PMID: 25656280

A Role for Panendoscopy? Second Primary Tumour in Early Stage Squamous Cell Carcinoma of the Oral Tongue

Overview
Journal J Laryngol Otol
Date 2015 Feb 7
PMID 25656280
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Panendoscopy is routinely used for the identification of occult second primary tumours in head and neck squamous cell carcinoma. However, its role in low risk subgroups, particularly non-smoking, non-drinking patients and patients presenting with early stage oral cavity lesions, is debatable.

Methods: The records of 112 patients with T₁ or T₂ oral tongue squamous cell carcinoma were retrospectively reviewed. Demographic, disease characteristics and survival data were collected.

Results: Average follow-up duration was 71.7 months (range, 3.6-238.3 months). Thirty-five patients died within this period. Thirteen second primary events were identified in 11 patients, with all but 2 tumours in the oral cavity or oropharynx. There was a single synchronous primary - a lung adenocarcinoma; all other events were metachronous. No non-smoking, non-drinking patients re-presented with a second primary tumour; tobacco and alcohol use are clearly risk factors for development of a second primary tumour.

Conclusion: The role of panendoscopy for identifying synchronous primary tumours in patients with early stage oral tongue squamous cell carcinoma should be re-evaluated, particularly in non-smoking, non-drinking patients who are at low risk of second primary development. Close follow up with regular clinical examination including flexible fibre-optic endoscopy may be sufficient in this subgroup.

Citing Articles

Panendoscopy for Head and Neck Cancers: Detection of Synchronous Second Primary Cancers, Complications and Cost-Benefit Analysis: A Systematic Review.

Bellavance S, Khoury M, Bissada E, Ayad T, Christopoulos A, Tabet J J Otolaryngol Head Neck Surg. 2025; 54:19160216251316215.

PMID: 39957633 PMC: 11831659. DOI: 10.1177/19160216251316215.


Clinical Analysis of Oral Squamous Cell Carcinoma: A Single-institution Experience.

Jiromaru R, Yasumatsu R, Matsuo M, Hashimoto K, Kogo R, Nakagawa T Cancer Diagn Progn. 2024; 4(2):105-110.

PMID: 38434924 PMC: 10905289. DOI: 10.21873/cdp.10294.


Risk of second primary cancer in patients with head and neck squamous cell carcinoma: a systemic review and meta-analysis.

Lu D, Zhou X, Sun H, Zeng B, Fu J, Gong J Clin Oral Investig. 2023; 27(9):4897-4910.

PMID: 37540282 DOI: 10.1007/s00784-023-05066-3.


Oncologic Panendoscopy: Description of an Optimized Procedure Based on Our Experience.

Pincet L, De Sandre C, Lang F, Colin V Int Arch Otorhinolaryngol. 2022; 26(1):e125-e131.

PMID: 35096169 PMC: 8789507. DOI: 10.1055/s-0041-1726049.


Alcohol and Head and Neck Cancer: Updates on the Role of Oxidative Stress, Genetic, Epigenetics, Oral Microbiota, Antioxidants, and Alkylating Agents.

Ferraguti G, Terracina S, Petrella C, Greco A, Minni A, Lucarelli M Antioxidants (Basel). 2022; 11(1).

PMID: 35052649 PMC: 8773066. DOI: 10.3390/antiox11010145.